BRAF and non-small cell lung carcinoma: Further analysis revealed a similar ratio of CD8 + T cells score to Treg score between the BRAF-mutated and WT NSCLC patients, indicating balanced recruitment between immune effector cells and suppressive cells driven by BRAF mutation.